Healthcare
The Big Picture: GE Healthcare’s Latest Acquisition Could Help Open A New Chapter In Precision Health
Julia Casey is a biochemical engineer by training, but she is also a deal-maker at heart. “I like doing deals,” says Casey, who serves as general manager of GE Healthcare’s Pharmaceutical Diagnostics Molecular Imaging business. “I like dealing with startups and thinking how we can leverage their skills and bring them in so we can really see the benefits of everything they’ve done, and the market and the patients can see the benefits of everything they’ve done.”
ST. LOUIS -- Nuclear medicine scanning will be enriched with the introduction of GE Healthcare's Discovery*^ NM/CT 670 Pro, announced today at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting (SNMMI 2014). The vision of quantitative accuracy in nuclear medicine is enabled by Q.Metrix^ and Q.AC^, GE Healthcare's newest software innovations in nuclear medicine.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
Technology can enable clinicians to assess patient's response to treatment accurately
WAUKESHA, Wisc. -- April 8, 2014 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that it received U.S. FDA 510(k) clearance of its Q.Clear^ technology -- technology that can provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. This is an innovative new tool for clinicians across the entire care continuum including diagnosis, staging, treatment planning, and treatment assessment.
business unit
tags
WAUKESHA, Wisc. -- Molecular Breast Imaging (MBI) Clinical Indications, Benefits and Challenges is the focus of a new CME credit course to be offered by ICPME® and funded in part by Gamma Medica, Inc. and in part by GE Healthcare. The one-hour online session will provide a thorough overview of MBI, which is a growing imaging technology for women with dense breasts and certain difficult-to-image cancers.
business unit
tags
CHICAGO -- December 4, 2013 -- As part of its ongoing commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company (NYSE: GE), will highlight the benefits of the company's broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America (#RSNA13) annual meeting.
business unit
tags
MILWAUKEE - GE Healthcare announced today that its Discovery* PET/CT 690 and PET VCAR 2.0 were used by Professor Patrick Flamen of the Institut Jules Bordet in Brussels in capturing the Society of Nuclear Medicine and Molecular Imaging 2013 "Image of the Year."
Professor Flamen's winning scan illustrated the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease. It was selected as the winning image from more than 2,000 studies.
business unit
tags
VANCOUVER, BC, CANADA, -- Today at the Society of Nuclear Medicine and Molecular Imaging meeting, GE Healthcare announced that it has received FDA clearance of its latest Xeleris† Processing and Review workstation software, adding to one of the most innovative suites of Molecular Imaging solutions in the industry.